A PHASE I SAFETY AND PHARMACOKINETIC STUDY OF EVEROLIMUS, AN ORAL MTOR INHIBITOR, IN SUBJECTS WITH IMPAIRED HEPATIC FUNCTION Статья Peveling-Oberhag J., Zeuzem S., Yong W.P., Kunz T., Paquet T., Bouillaud E., Urva S., Anak O., Sellami D., Kobalava Z. EUROPEAN JOURNAL OF CANCER. ELSEVIER SCI LTD. Том 47. 2011.
VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN NONPREGNANT HUMAN ENDOMETRIUM AND ITS GENETIC POLYMORPHISMS: CONTRIBUTION TO RECURRENT PREGNANCY LOSS Статья Sadekova O.N., Nikitina L.A., Rashidov T.N., Demidova E.M., Samokhodskaya L.M. Placenta. W.B. Saunders Ltd. Том 32. 2011.